Pilihan
Constellation Brands Reports Full Fiscal Year and Fourth Quarter 2026 Financial Results
ROCHESTER, N.Y., April 08, 2026 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, reported today its full fiscal year and fourth quarter 2026 financial results. A conference call to discuss the financial results and outlook will be hosted by President and Chief Executive Officer, Bill Newlands, and Executive Vice President and Chief Financial Officer, Garth Hankinson, on Thursday, April 9, 2026, at 8:00 a.m. ET. Incoming President and CEO Nicholas Fink will also join at the beginning of the call to provide brief remarks before turning the call over to Mr. Newlands and Mr. Hankinson to conduct the question-and-answer session. Visit ir.cbrands.com to locate information for joining the conference call, or a live, listen-only webcast of the conference call.
ABOUT CONSTELLATION BRANDS
Constellation Brands (NYSE: STZ) is a leading international producer and marketer of beer, wine, and spirits with operations in the U.S., Mexico, New Zealand, and Italy. Our mission is to build brands that people love because we believe elevating human connections is Worth Reaching For. It’s worth our dedication, hard work, and calculated risks to anticipate market trends and deliver for our consumers, shareholders, employees, and industry. This dedication is what has driven us to become one of the fastest-growing, large CPG companies in the U.S. at retail, and it drives our pursuit to deliver what’s next.
Every day, people reach for brands from our high-end, imported beer portfolio anchored by the iconic Corona Extra and Modelo Especial, a flavorful lineup of Modelo Cheladas, and favorites like Pacifico, and Victoria; our exceptional wine brands including The Prisoner Wine Company, Robert Mondavi Winery, Kim Crawford, Schrader Cellars, and Lingua Franca; and our craft spirits brands such as Casa Noble Tequila and High West Whiskey.
As an agriculture-based company, we strive to operate in a way that is sustainable and responsible. Our ESG strategy is embedded into our business and we focus on serving as good stewards of the environment, investing in our communities, and promoting responsible beverage alcohol consumption. We believe these aspirations in support of our longer-term business strategy allow us to contribute to a future that is truly Worth Reaching For.
To learn more, visit www.cbrands.com and follow us on LinkedIn and Instagram.
MEDIA CONTACTS
Amy Martin 585-678-7141 / amy.martin@cbrands.com
INVESTOR RELATIONS CONTACTS
Blair Veenema 585-284-4433 / blair.veenema@cbrands.com
Snehal Shah 847-385-4940 / snehal.shah@cbrands.com
David Paccapaniccia 585-282-7227 / david.paccapaniccia@cbrands.com
A PDF containing our Fiscal Year and Fourth Quarter 2026 financial results and full financial tables is available at: http://ml.globenewswire.com/Resource/Download/ee30bd34-a090-4367-9e24-3cb70e16f244
Copyright © 2026 GlobeNewswire, Inc.
.png)

Berita Lainnya
SpaceX Resmi Tercatat di Bursa: SPCX Kini Tersedia untuk Diperdagangkan Setelah Debut Bersejarah di Nasdaq
*urban-gro, Inc. (Nasdaq: UGRO) Announces Lanka Premier League Season 6 - Potential Record 600-Player Pool, ......
OFF BEAUTY Announces National Expansion as Korea's First Discount Beauty Outlet Chain with Up to 90% Discounts
CNH mengumumkan hasil pemungutan suara Rapat Umum Tahunan 2026 dan menerbitkan Laporan Keberlanjutan 2025
From plastic waste to chocolate wrappers: LYB and Mondelez collaborate on Marabou flexible packaging sourced from recycled plastic
Copenhagen Infrastructure Partners completes acquisition of Ørsted’s European onshore platform – and launches Perigus Energy
Bitget Launches Universal Cup With 250,000 USDT Prize Pool
Hainan Tourism Promotion Seminar Lands in Madrid, Paving the Way for Deeper Cultural and Tourism Ties Between China and Spain
Challenge accepted: Schneider Electric helps industry turn toughest problems into competitive advantage
SpaceX Resmi Tercatat di Bursa: SPCX Kini Tersedia untuk Diperdagangkan Setelah Debut Bersejarah di Nasdaq
Invitation - 2026 Half-Year Results Conference for Analysts and Investors
Junshi Biosciences Announces Approval of Toripalimab NDA for the 1st-line treatment of HER2 Expressing Urothelial Carcinoma